All Type of News
In Korea, OTC ‘Centrum’ has been freely sold in online shopping malls
Pfizer Pharmaceuticals Korea’s multivitamins categorized as a OTC drug in Korea, ‘Centrum’ has freely been sold in online shopping malls, not pharmacies.
According to the result of searching Centrum in a famous domes...
A series of WHO PQ triggers vaccines development of domestic pharmaceutical companies
A series of the WHO PQs by domestic pharmaceutical and biopharmaceutical companies are expected to accelerate the domestic vaccine development.
A pentavalent complex vaccine developed by LG Life Sciences for the firs...
GSK’s HIV treatment, ‘Triumeq’ lands in approximately s30 major hospitalsGSK(CEO Yoo-seok Hong) invigorates ‘Triumeq’ prescriptions.
According to GSK, ‘Triumeq(dolutegravir 50mg, abacavir 600mg, lamivudine 300mg),’ a complex HIV treatment which cont...
|
MFDS raises to ICH observer, considered to apply for member country this year
As becoming an observer of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use(ICH), the Ministry of Food and Drug Safety(MFDS) has safely established a foundation t...
Samsung’s partner, Biogen files patent infringement trial against Celltrion
Biogen Idec, the patentee of Mabthera(foreign name: Rituxan), applied for a judgment for the patent infringement against Celltrion.
Biogen is not only the second largest shareholder holding 9.7% of the entire Samsung...
What are Celltrion’s future schedule after the entry to the U.S. market?The future direction of ‘Remsima,’ a Celltrion’s biosimilar antibody, has attracted attention as receiving the approval recommendation from the U.S. FDA Arthritis Advisory Commi...
|
Celltrion’s Remsima receives ‘approval recommendation’ for all indicationsOn the 9th of February(local time), Celltrion announced the first biosimilar antibody, ‘Remsima,’ received ‘approval recommendation’ for all the indications applied from the U.S...
|
Hastened development and commercialization of ‘rare drugs’ for rare disease patients
The Ministry of Food and Drug Safety(Minister Seung-hee Kim, MFDS) announced it gave a administrative notice for 6 amendments, such as the ‘Regulation to Indicate Rare Drugs,’ containing the contents to establish acti...
What is the current trend for ‘anticancer’ clinical pipelines?
Approaches for R&Ds, including Open Innovation, have never been more diversified over new drug candidates. Domestic pharmaceutical companies are also racing to strengthen their new drug pipelines to follow the trend.
...
Raised status of domestic anticancer drugs
‘Supect(radotinib)’ developed by Ilyang Pharmaceutical emerged in the leukemia treatment market which used to be occupied only by multinational companies. Anticancer treatments are no longer multinational companies’ e...
